The BLP25 is a lipopeptide containing 25 amino acid sequences that provide MUC1 specificity.71 After the encouraging results of the phase II trial (START), a phase III trial and INSPIRE were conducted in NSCLC patients. The gene discussed is MUC1; the disease is non-small cell lung carcinoma.